ATAGI

2022 - 7 - 7

atagi 4th dose atagi 4th dose

Post cover
Image courtesy of "ABC News"

COVID-19 fourth-dose boosters offered for all people over 30 (ABC News)

This media is not yet available. Eligibility of fourth COVID-19 vaccine expanded to all Australians aged over 30. Share this article.

The fourth dose was already available to people aged over 65, aged care residents, Aboriginal and Torres Strait Islander people aged 50 and older, people with a disability, the immunocompromised and anyone over 16 with a medical condition that increases the risk of severe COVID-19. "My message to everyone living in Australia aged 50 and over is to make sure you have the greatest protection against COVID-19 by having a fourth dose as soon as possible," Mr Butler said. The Australian Technical Advisory Group on Immunisation (ATAGI) specifically recommended the shot for people over 50, while people aged 30 to 49 may choose to have a fourth dose. - A fourth dose may also be offered to people aged 30 to 49 - ATAGI has recommended people over 50 receive a fourth dose of the COVID vaccine The nation's expert vaccine advisory body has recommended that anyone older than 50 receive a fourth dose of the COVID-19 vaccine.

Post cover
Image courtesy of "The Canberra Times"

More people to get fourth COVID vax: ATAGI (The Canberra Times)

From July 11, people over 50 will be recommended to receive a fourth vaccine dose, or second booster shot. Advertisement. Ad.

Advertisement Advertisement Advertisement

Post cover
Image courtesy of "The Mandarin"

ATAGI recommends winter booster COVID-19 dose for over 50s (The Mandarin)

The Australian Technical Advisory Group on Immunisation is reviewing evidence on COVID-19 booster shots for the winter season.

We are at the start of a 3rd COVID-19 Omicron wave and expect to see a significant rise in cases. The ATAGI said in a statement its goal is to minimise severe risks from COVID-19, including hospitalisation and death. Please continue to do the little things: stay home when unwell, test if you have symptoms & stay up to date with your vaccinations. “We’re not ruling anything out in terms of introducing mask requirements and that kind of thing. “Increasing the uptake of winter booster doses of COVID-19 vaccine in populations most at risk during this time is anticipated to play a limited, but important role in reducing the risk from COVID-19 to individuals and pressure on the healthcare system,” a statement read. The ATAGI said the updated recommendations were a result of the strain on the health system from the recent surge in cases, which the organisation said was expected to worsen.

Post cover
Image courtesy of "Australian Government Department of Health"

ATAGI updated recommendations for a winter dose of COVID-19 ... (Australian Government Department of Health)

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the COVID-19 vaccine winter dose.

However, a winter booster dose remains recommended for individuals aged 16 years or more who have a higher risk of severe outcomes from COVID-19 (i.e. they are immunocompromised or have a complex medical condition or disability) as they are most likely to benefit. Based on first principles and currently available evidence, reaching a higher level of coverage of the COVID-19 winter booster dose in older adults, including those aged 50 to 64 years, is likely to reduce the number of COVID-19 related hospitalisations over the coming months. ATAGI recognises that some people aged 30 to 49 years would also like to reduce their risk of infection from COVID-19 and therefore may consider a winter booster dose. This includes increased use of masks and increasing the use of antiviral treatment in people diagnosed with COVID-19, including in people aged 50 years and above. Reducing the interval between a first booster dose and a winter dose from 4 months to 3 months will also help provide earlier protection as infection rates rise. A surge in cases of COVID-19 from the SARS-CoV-2 Omicron BA.4 and BA.5 subvariants is a contributing factor and is expected to worsen in the coming months. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5. Lancet Infect Dis. 2022 Jun 28:S1473-3099(22)00422-4. doi: 10.1016/S1473-3099(22)00422-4. Epub ahead of print. 2 A winter dose (the second booster dose) is anticipated to boost this immune response. Increasing the uptake of winter booster doses of COVID-19 vaccine in populations most at risk during this time is anticipated to play a limited, but important role in reducing the risk from COVID-19 to individuals and pressure on the healthcare system. Available from:The New England Journal of Medicine doi: 10.1056/NEJMc2206576. Epub ahead of print. 2,3 A first booster dose of COVID-19 vaccine has been shown to increase the immune response to these new subvariants, but wanes over several weeks.

Post cover
Image courtesy of "3AW"

LATEST: ATAGI announces new recommendations for COVID ... (3AW)

Australians aged 30 and over are now eligible to get their fourth dose of a COVID vaccine. The health minister announced the news on Thursday.

ATAGI has specifically recommended those aged over 50 should have their fourth dose, while those aged 30-49 may also choose to get one. It means an additional 7.4 million Australians are now eligible for their second booster. Australians aged 30 and over will be eligible to get their fourth dose of a COVID vaccine from Monday.

Post cover
Image courtesy of "Sky News Australia"

Fourth COVID-19 jab to be approved for over 30s (Sky News Australia)

Australians over the age of 30 will have access to a fourth COVID-19 jab from as early as this week as infections and hospitalisations continue to surge.

"It's been in place for a couple of weeks in the Eastern states moving its way westward across South Australia, my state, and WA as well. New to Flash? Try 1 month free. Stream more COVID-19 news live & on demand with Flash. 25+ news channels in 1 place.

Post cover
Image courtesy of "Neos Kosmos"

ATAGI advises 50-64 age group to get COVID-19 winter booster (Neos Kosmos)

ATAGI is recommending that adults between the ages of 50 to 64 years should receive a winter booster dose of a COVID-19 vaccine.

Increasing the uptake of winter booster doses of COVID-19 vaccine in populations most at risk during this time is anticipated to play a limited, but important role in reducing the risk from COVID-19 to individuals and pressure on the healthcare system,” ATAGI said. However, a winter booster dose remains recommended for individuals aged 16 years or more who have a higher risk of severe outcomes from COVID-19.” The Australian Technical Advisory Group on Immunisation (ATAGI) is recommending that adults between the ages of 50 to 64 years should receive a winter booster dose of a COVID-19 vaccine while adding that people aged 30 to 49 years could receive a winter booster dose but the benefits of doing so were less certain.

ATAGI expands Winter COVID-19 dose eligibility (Premier of Tasmania)

The Australian Technical Advisory Group on Immunisation (ATAGI) has today updated its recommendations for Australians eligible to receive their second ...

From Monday 11 July 2022, adults aged 50-64 years of age will be recommended to receive their winter booster of the COVID-19 vaccine. This three-month interval also applies following the infection of COVID-19. Winter booster doses will be available in state-run clinics and at participating GP and pharmacy clinics across Tasmania from Monday 11 July 2022 and we encourage you to speak to your vaccine provider about which COVID-19 vaccine is most suitable for you.

More people to get fourth COVID vax: ATAGI (Port Macquarie News)

More than seven million people will be able to get a fourth dose of a COVID-19 vaccine, after...

ACT: 1292 cases, no deaths, 135 in hospital with six in ICU WA: 6387 cases, eight deaths, 240 in hospital with 12 in ICU NT: 353 cases, no deaths, 19 in hospital with none in ICU Tasmania: 1728 cases, no deaths, 80 in hospital with three in ICU We have lots of capacity in the system." Victoria: 10,265 cases, 12 deaths, 592 in hospital with 30 in ICU

Explore the last week